COVID-19 and the Developement of Phobic Fears of Disease

NCT04359121 | Unknown

• 1 other identifier: 32-354 ex 19/20
• Study Type: observational
• Target: 600
• Locations: 1 country
• Sites: 1

Brief Summary

A lot of people suffer from phobias. Phobias concerning certain diseases are not rare. This study will examine whether the COVID-19 (Coronavirus Disease) crisis was able to rise phobias in people and if those with preexisting phobias or fears were more likely to develop a phobia concerning COVID. It will look at different subtypes - physicians, medical staff, general public (not medically affiliated) and patients with psychiatric disorders.

Conditions

COVID19

Outcome Measures

Primary Outcomes (1)

• Development of phobias

  Specific Phobia Questionnaire (SPQ): The SPQ consists of 43 items, each rated using a 5-point Likert scale on two dimensions: (1) level of fear, with scores ranging from 0 (no fear) to 4 (extreme fear) and (2) extent to which the fear interferes with one's daily life, with scores ranging from 0 (no interference) to 4 (extreme interference). The SPQ is scored by combining fear ratings of each Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) specific phobia type. Severity Measure for Specific Phobia-Adult: The total score can range from 0 to 40 with higher scores indicating greater severity of specific phobia.

  2 years

Study Arms (4)

Physicians

Questionnaires

Other: Questionnaires for specific phobia

Medical staff

Questionnaires

Other: Questionnaires for specific phobia

General public

Questionnaires

Other: Questionnaires for specific phobia

Patients with psychiatric disorders

Questionnaires

Other: Questionnaires for specific phobia

Interventions

Questionnaires for specific phobia OTHER

Questionnaires will be used.

General public; Medical staff; Patients with psychiatric disorders; Physicians

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

physicians, medical staff, general public, patients with psychiatric disorders

You may qualify if:

• Person gives written consent
• Persons between 18-90 years of age (men and women)
• No positive COVID infection known at time of first examination

You may not qualify if:

• Dementia, Delirium (not able to give consent)
• COVID infection known at first examination point

Sponsors & Collaborators

• Medical University of Graz: lead

Study Sites (1)

Medical University of Graz

Graz, Styria, 8036, Austria

RECRUITING

MeSH Terms

Conditions

COVID-19

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Andreas Baranyi, Prof.

  Medical University of Graz

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Andreas Baranyi, Prof.

CONTACT

0043-316-385-86241; an.baranyi@medunigraz.at

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 21, 2020
• First Posted: April 24, 2020
• Study Start: December 15, 2020
• Primary Completion: November 15, 2023
• Study Completion: November 15, 2023
• Last Updated: January 11, 2023

Record last verified: 2023-01

Data Sharing

• IPD Sharing: Will not share

Locations

AU (1)